Endoscopy 2004; 36(2): 183-185
DOI: 10.1055/s-2004-814188
Case Report
© Georg Thieme Verlag Stuttgart · New York

Dieulafoy’s Lesion of the Esophagus Correctly Diagnosed and Successfully Treated by the Endoscopic Injection of N-Butyl-2-Cyanoacrylate

T.  Yoshida1 , K.  Adachi2 , Y.  Tanioka1 , T.  Sasaki2 , S.  Ono2 , H.  Hanada2 , T.  Esaki2 , T.  Yagawa1 , S.  Takeo1 , Y.  Saiki1 , T.  Harada1 , K.  Okita1
  • 1Molecular Science and Applied Medicine, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine, Yamaguchi, Japan
  • 2Saiseikai Yamaguchi General Hospital, Yamaguchi, Japan
Weitere Informationen

Publikationsverlauf

Submitted 20 November 2002

Accepted after Revision 21 May 2003

Publikationsdatum:
06. Februar 2004 (online)

Dieulafoy’s lesion is an arterial malformation in the subumucosal layer of the gastrointestinal tract that can cause massive bleeding. The esophagus is not a common location for this lesion. We present here a first report of Dieulafoy’s lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylate.

References

  • 1 Dieulafoy G. Exulceratio simplex.  Bull Acad Med. 1898;  39 49-84
  • 2 Juler G L, Labitzke H G, Lamb R, Allen R. The pathogenesis of Dieulafoy’s gastric erosion.  Am J Gastroenterol. 1984;  79 195-200
  • 3 Ikeda Y, Tamakawa R, Hatakeyama H. et al . Evaluation of endoscopic local injection of hypertonic saline-epinephrine solution and surgical treatment on hemorrhagic gastroduodenal ulcer.  Nippon Geka Gakkai Zasshi. 1989;  90 1545-1547 [In Japanese]
  • 4 Kasapidis P, Georgopoulos P, Delis V, Balatsos V. et al . Endoscopic management and long-term follow-up of Dieulafoy’s lesions in the upper GI tract.  Gastrointest Endosc. 2002;  55 527-531
  • 5 Ertekin C, Barbaros U, Taviloglu K. et al . Dieulafoy’s lesion of esophagus.  Surg Endosc. 2002;  16 219
  • 6 Iso Y, Kawanaka H, Tomikawa M. et al . Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices: a prospective randomized trial.  Hepatogastroenterology. 1997;  44 467-471
  • 7 Soehendra N, Grimm H, Nam V C. et al . N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.  Endoscopy. 1987;  19 221-224
  • 8 Sheikh R A, Trudeau W L. Clinical evaluation of endoscopic injection sclerotherapy using N-butyl-2-cyanoacrylate for gastric variceal bleeding.  Gastrointest Endosc. 2000;  52 142-144

T. Yoshida, M. D., Ph. D.

Molecular Science and Applied Medicine, Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine

1-1-1 Minami-Kogushi · Ube · Yamaguchi 755-8505 · Japan

Fax: + 81-836-222240

eMail: tyoshida@yamaguchi-u.ac.jp